Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease diabetes mellitus, insulin-dependent
Symptom C0022658|kidney disease
Sentences 17
PubMedID- 22533709 reported that plasma ctgf was increased in type 1 diabetes subjects with kidney disease, compared to those with normoalbuminuria, but there were no significant associations of the −945 g/c polymorphism with plasma ctgf levels or cardiovascular mortality, non-fatal cardiovascular events and end-stage kidney disease.
PubMedID- 24793984 However, urine agt concentration has not been reported in type 1 diabetes with kidney disease.
PubMedID- 24165454 Early treatment of hypertension has been reported to prevent end-stage kidney disease in patients with type 1 diabetes .
PubMedID- 21307382 In the context of type 1 diabetes, and especially in patients with chronic kidney disease (ckd) who have the greatest risk of adverse outcomes (7,8), activation of these pathways may offset or overshadow any gains achieved from modest and transient blood pressure lowering.
PubMedID- 25027389 Aims: improved early diagnostic methods are needed to identify risk for kidney disease in people with type 1 diabetes.
PubMedID- 21883436 Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver.
PubMedID- 26273678 The patients suffering from cancer, acute inflammation, liver and kidney disease, patients with type 1 diabetes, and patients recently taking drugs that may interfere with glucose and lipid metabolism were not included in the present study.
PubMedID- 22540522 Early detection of kidney disease in type 1 diabetes: what do we really know.
PubMedID- 22728293 Background: simultaneous pancreas-kidney transplantation (spkt) is a promising therapy for type 1 diabetes mellitus with chronic kidney disease.
PubMedID- 21840097 Background: kidney disease in patients with type 1 diabetes historically has been believed to be more prevalent in men.
PubMedID- 24696459 Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
PubMedID- 23028342 New susceptibility loci associated with kidney disease in type 1 diabetes.
PubMedID- 24455970 Nonalcoholic fatty liver disease (nafld) is associated with an increased prevalence of chronic kidney disease in patients with type 1 diabetes.
PubMedID- 21698141 For example, the 4.1 protein ezrin, radixin, moesin ferm domain containing 3 locus (frmd3) was implicated in kidney disease attributed to type 1 diabetes (t1dm) in european americans from the genetics of kidneys in diabetes (gokind) collection, with replication based upon nephropathy progression rates in subjects with t1dm in the diabetes control and complications trial (dcct)/epidemiology of diabetes interventions and complications (edic) study .
PubMedID- 26310691 The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes.
PubMedID- 23303408 Our objective was to study the effect of apelin on the progression of kidney disease in mice with established type 1 diabetes.
PubMedID- 23835686 Our primary finding is a stepwise increased odds for cac progression in type 1 diabetes with progressive kidney disease and increased odds even with normal renal function.

Page: 1